US Patent Issued to ESTEVE PHARMACEUTICALS on Nov. 25 for "Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against pain" (Spanish Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,830, issued on Nov. 25, was assigned to ESTEVE PHARMACEUTICALS S.A. (Barcelona, Spain).

"Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against pain" was invented by Carmen Almansa-Rosales (Barcelona, Spain), Ariadna Fernandez-Donis (Barcelona, Spain), Jose-Luis Diaz-Fernandez (Barcelona, Spain), Monica Garcia-Lopez (Barcelona, Spain), Sergi Rodriguez Escrich (Barcelona, Spain) and Ute Christmann (Viladecans, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having dual pharmacological activity tow...